DPhil Students: Carl welcomes informal contacts from students in the field of evidence-based medicine

Carl Heneghan is a clinical epidemiologist with expertise in evidence-based medicine, research methods, and evidence synthesis expertise. 

He has over 450 peer-reviewed publications (current H index 96) and published 110 systematic reviews. 

His work includes investigating the evidence for approval of drugs and devices, assessing health claims and researching common presenting conditions in the community.

He has investigated antivirals, including Tamiflu, acute respiratory infections, and the transmission of SARs-CoV-2. He is also an expert in medical device regulation, diagnosis and screening, and avoidable le harms.

Impact projects include the COVID-19 Evidence Service,  anticoagulation care, Primodos & congenital malformations, the harms of transvaginal mesh  and the transmission of SARs-CoV-2 (see cebm research)

He is a clinical advisor to two UK All Parliamentary Party Groups, an adviser to the WHO clinical trials registry platform, and a founder of the AllTrials campaign. The HSJ voted him twice as one of the top 100 NHS clinical leaders. In 2018, he was awarded NIHR Senior Investigator status.  

Teaching:

In 2019, he received a lifetime achievement award from Oxford's Medical Science Division for his sustained commitment to education and teaching. He is the Director of the Centre for Evidence-Based Medicine (CEBM), which builds capacity through teaching and training activities. He teaches undergraduates, postgraduates and teachers of EBM and is Director of Programs in Evidence-Based Health Care,

Dissemination and Media: See an expert page

He regularly podcasts his talks on iTunes, has an active Twitter account @carlheneghan, is a columnist for the Spectator and writes regularly at Trust the Evidence

Global Centre for Healthcare and Urbanisation (GCHU)

He is co-director of the GCHU based at Kellogg College, which has been established to foster a better understanding of the interaction between healthcare and urbanisation. 

OUGC:

He is the President/Senior Member of the Oxford University Golf Club

Conflicts of interest and payments:

He holds grant funding from the NIHR and previously from the WHO for a series of Living rapid reviews on the modes of transmission of SARs-CoV-2 reference WHO registration 2020/1077093 that are ongoing. He has received financial remuneration from an asbestos case and given legal advice on mesh, hormone pregnancy tests and sodium valproate. He receives expenses and payments for his media work and teaching EBM, and his GP works out of hours in the NHS. He has received income from publishing a series of toolkit books for appraising treatment recommendations in non-NHS settings and evidence reviews. He is an advisor to Collateral Global, the Sir James Mackenzie Institute for Early Diagnosis at St Andrew's University, and the WHO's International Clinical Trials Registry Platform (ICTRP) and is a member of the Board of Preventing Overdiagnosis. He is also the co-director of the Global Centre for Healthcare and Urbanisation.